Heart failure drugs show cardioprotective benefits for cancer patients undergoing treatment

A presentation at ESC Cardio-Oncology 2026 demonstrated that heart failure treatments can protect heart function in cancer patients undergoing cancer therapy. Cancer treatments often cause cardiovascular side effects that may force discontinuation of anticancer therapy, reducing